Therapies that boost anti-HER2 immunity may help reduce risk of HER2-positive breast

[News]

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient's immune system -- a weakness that in principle could be corrected with a HER2-targeted vaccine -- according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

More... (http://www.news-medical.net/news/20151231/Therapies-that-boost-anti-HER2-immunity-may-help-reduce-risk-of-HER2-positive-breast-cancer-recurrence.aspx)